Retrospective Study
Copyright ©The Author(s) 2017.
World J Cardiol. May 26, 2017; 9(5): 442-447
Published online May 26, 2017. doi: 10.4330/wjc.v9.i5.442
Table 2 Angiographic and procedural characteristics
No PMI (n = 270)PMI (n = 23)P value
Vessels involved0.68
LM bifurcation15.9%21.7%
LAD/Diagonal40.0%47.8%
LCX/OM34.8%21.7%
RPDA/RPLA8.8%4.3%
RCA/RV marginal0.003%0%
Severe calcification57.4%65.2%0.52
True bifurcation (Medina 1,1,1; 1,0,1; 0,1,1)79.3%91.3%0.27
Main vessel diameter (mm)3.3 ± 0.53.3 ± 0.40.4
Side branch diameter (mm)2.6 ± 0.52.6 ± 0.40.94
Antiplatelet therapy0.97
Plavix73.7%69.6%
Prasugrel7.0%8.7%
Ticagrelor19.3%21.7%
Anticoagulant0.08
Heparin45.2%65.2%
Bivalirudin54.8%34.8%
Upstream GpIIb/IIIa use11.5%13.0%0.74
Planned 2 stent approach28.1%39.1%0.34
Final kissing balloon angioplasty45.9%56.5%0.39
SB protected73.3%87%0.21
PGW jailed15.9%43.4%0.003